| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ | Director | Common Stock | 1.44M | $17.2M | $12.00 | Jan 22, 2024 | Indirect |
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Common Stock | 1.67M | $16.7M | $9.98 | Dec 3, 2024 | Indirect |
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Common Stock | 241K | $2.41M | $9.98 | Dec 4, 2024 | Direct |
| Zai Lab Ltd | Director | American Depositary Shares | 61.8K | $1.32M | $21.33 | Jun 18, 2024 | Direct |
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 1.49M | Sep 12, 2024 | Direct | ||
| TREVENA INC | Director | Stock Option (Right to Buy) | 13.7K | Jun 15, 2023 | Direct | ||
| Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 11K | May 23, 2024 | Direct | ||
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Series A Convertible Preferred Stock | 0 | Sep 16, 2024 | Direct | ||
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Series B Convertible Preferred Stock | 0 | Sep 16, 2024 | Direct | ||
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Series B Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect | ||
| Zenas BioPharma, Inc. | Chief Executive Officer, Director | Series Seed Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Dec 3, 2024 | 2 | $718K | 4 | Dec 4, 2024 | Chief Executive Officer, Director |
| ZBIO | Zenas BioPharma, Inc. | Nov 18, 2024 | 2 | $149K | 4 | Nov 20, 2024 | Chief Executive Officer, Director |
| ZBIO | Zenas BioPharma, Inc. | Sep 18, 2024 | 4 | $361K | 4 | Sep 20, 2024 | Chief Executive Officer, Director |
| ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 9 | $0 | 4/A | Sep 17, 2024 | Chief Executive Officer, Director |
| ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Chief Executive Officer, Director |
| ZLAB | Zai Lab Ltd | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Jan 22, 2024 | 1 | $2M | 4 | Jan 24, 2024 | Director |
| MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 1 | $0 | 4 | Sep 13, 2023 | Director |
| MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 0 | $0 | 3 | Sep 13, 2023 | Director |
| ZLAB | Zai Lab Ltd | Jun 29, 2023 | 1 | $500K | 4 | Jun 30, 2023 | Director |
| TRVN | TREVENA INC | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| TRVN | TREVENA INC | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| ZLAB | Zai Lab Ltd | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |
| TRVN | TREVENA INC | May 28, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |